The global antihistamine product market was valued at USD 263.9 billion in 2022. The market is expected to expand at a CAGR of 8.6% and reach a valuation of ~USD 647.7 billion by 2033.
| Data Points | Market Insights |
|---|---|
| Antihistamine Market Value, 2022 | USD 263.9 billion |
| Antihistamine Market Value, 2023 | USD 284.2 billion |
| Antihistamine Market Value, 2033 | USD 647.7 billion |
| CAGR (2023 to 2033) | 8.6% |
| Market Share of Top 5 Countries | 50.5% |
| Key Market Players | GlaxoSmithKline PLC., Sanofi Consumer Healthcare, Himalaya Wellness Company, Sun Pharmaceutical Industries, Inc., Bayer AG, Novartis AG, Cadila Pharmaceuticals, Bausch Health Companies Inc., Alcon Vision LLC., Merck & Co., Dr. Reddy’s Laboratories, Ltd., Viatris Inc., Somerset Pharma, LLC, F. Hoffmann- La Roche Ltd., Akorn Operating Company LLC, Teva Pharmaceutical Industries Ltd., Speer laboratories, Glenmark Pharmaceuticals Limited, TerSera Therapeutics LLC, Pfizer Inc., Morepen Laboratories Limited, Johnson & Johnson Sevices Inc., Pharmaceutical Specialties Inc., Proctor & Gamble |
The antihistamine market has observed significant growth over the last decade. The increasing prevalence of allergies and allergic reactions across the globe has expanded the growth of the antihistamine market. Antihistamine drugs are used to treat a variety of allergies and allergic reactions, as it is an anti-allergic medication.
The body acts on certain histamine receptors and releases histamine throughout an allergic reaction. Antihistamine can also treat pruritus-related conditions such as atopic dermatitis, insect bites, and other conditions. Moreover, H-1 and H-2 types of antihistamine are used to treat other conditions such as insomnia, motion sickness, anxiety and heartburn, gastric ulcers, and others, respectively.
The market value for antihistamines was approximately 1.3% of the overall global allergy treatment market worth ~USD 19,070.0 billion in 2022.
| Historical Antihistamine Market Value (2022) | USD 263.9 billion |
|---|---|
| Historical CAGR (2017 to 2022) | 5.9% |
The sale of antihistamines expanded at a CAGR of 5.9% from 2017 to 2022. The demand for antihistamine products will keep up strong in the years ahead.
The preference for antihistamine drugs for treatment procedures is growing as the accessibility of these drugs is highly convenient through retail pharmacies, hospital pharmacies, and online pharmacies. This is one of the factors influencing the production growth of antihistamines. Numerous manufacturers are utilizing different antihistamine dosage forms to enhance their market share.
Allergic reactions caused on the skin are distinguished by red, peeling, dry, swollen surface, itch, and rash. The most common triggering factor for allergies is the overreaction of histamine in the body; this is when antihistamines come into action. Antihistamines assist in reducing inflammation, which usually alleviates the pain.
Apart from that, skin conditions such as allergic rhinitis can occur due to prolonged and repeated exposure to dust mites, molds, or pet dander. It can further lead to symptoms such as nasal congestion and irritation in the nose, throat, and eyes, increasing the growth of the antihistamine market.
Medical professionals prescribe antihistamines to relieve symptoms of insomnia as well. Due to the current environment and lifestyle, such as unstable working shifts, smoking, varied sleeping patterns and others, the antihistamine market has witnessed growth in conditions such as insomnia, which is the most common issue among the general population today.
According to an article published by the American Journal of Managed Care in 2020, around 30% to 40% of the USA adult population develop symptoms of insomnia per year. The inability to fall asleep or stay asleep can have a major influence on productivity and mood. It can be a symptom or a cause of other underlying medical disorders.
Easily available over-the-counter drugs such as diphenhydramine can assist in sleeping aids. An antihistamine is not a first-line treatment for insomnia but first-generation antihistamine blocks H-1 histamine receptors, which can cause sedation and make the patients drowsy. These factors can be favorable for the antihistamine market.
Thus, owing to the aforementioned factors, the global market is expected to grow at a CAGR of 8.6% during the forecast period from 2023 to 2033.
The growth will be driven by the increasing concerns regarding the prevalence of allergic reactions and other conditions such as urticaria and anxiety across the globe. Further, the market opportunistic outlook is owing to the increasing investments in research and development, due to which drug approvals are rising and new products concerning antihistamine drugs are being launched, which is expanding the market.
For instance, in May 2022, Glenmark Pharmaceuticals launched a nasal spray in India named Ryaltris-AZ. Ryaltris-AZ was introduced as the first-line treatment for allergic rhinitis with a mixture of intranasal antihistamines and corticosteroids.
Moreover, a number of manufacturers are expanding their line of medications by providing antihistamine drugs in multiple routes of administration, increasing the range of antihistamine-related products in the market. Hence, in the forthcoming years, the antihistamine market is expected to dispense lucrative growth opportunities.
Sometimes, due to a lack of awareness among the rural population in some developing countries, it becomes difficult to cope with allergies and other conditions. It is because of negligence and inability to seek medical help. This is a crucial factor hampering the growth of the market.
Antihistamine blocks the process of histamine, but at times, there are a few side effects that can be caused due to antihistamines. These side effects include drowsiness, dry mouth, dry eyes, sore throat, and others. This factor acts as a barrier and affects the growth of the market in a negative manner.
| Countries | CAGR (2023 to 2033) |
|---|---|
| United States | 8.9% |
| China | 8.6% |
| United Kingdom | 8.0% |
| Germany | 8.2% |
| India | 7.8% |
The United States dominates the North American region, with a total market share of about 85.4% in 2022. The market is expected to grow at a CAGR of 8.9% through 2033.
According to the Centers for Disease Control and Prevention, more than 60 million people per year in the United States suffer from hay fever. It was also reported that seven out of ten patients in 2020 were suffering from hay fever along with allergic conjunctivitis that causes red, watery, and itchy eyes. The prevalence of allergies in the USA is driving the market. There are numerous antihistamine medications that provide relief from such inflammation symptoms. These are the prime drivers for the market within the country.
China dominates the East Asian region with a total market share of about 51.2%. It is estimated to grow at a CAGR of 8.6% throughout the forecast period.
Allergic rhinitis is becoming a major concern in terms of health and economy in China. Children in China are more prone to such disorders due to allergens like house dust mites. As the prevalence of allergies and allergic reactions is rising, the demand for antihistamines is increasing, boosting market growth.
India is set to exhibit a CAGR growth rate of nearly 7.8% during the forecast period. Due to the increasing prevalence of allergic conjunctivitis in the general population of India, the consumption of the antihistamines for the treatment is increasing, contributing to the growth of the Indian market.
Allergy-based disorders in India are becoming a matter of concern due to factors like the illiteracy among the rural population and paucity of allergy specialists.
| Top Product | H-1 blockers |
|---|---|
| CAGR (2023 to 2033) | 8.9% |
H-1 blockers are expected to present high growth at a CAGR of 8.9% over the forecast period, with a market share of about 55.9%. H-1 antihistamines can alleviate the pain caused by allergic conjunctivitis, skin rashes and hypersensitivity toward certain drugs.
| Top Type | Over-the-counter |
|---|---|
| CAGR (2023 to 2033) | 9.0% |
Over-the-counter antihistamines are dominating the market with a share of 51.3% in 2022. This segment is expected to present high growth at a CAGR of 9.0% by the end of the forecast period. Antihistamine drugs are easily available through over-the-counter means. Therefore, this segment is considered to be dominant in the type category.
| Top Dosage | Tablets |
|---|---|
| CAGR (2023 to 2033) | 9.7% |
Tablets hold a market share of 35.0% in 2022 and are expected to display gradual growth over the forecast period, with a CAGR of 9.7%. Tablets are one the most convenient and economical dosage forms of antihistamines.
| Top Route of Administration | Oral |
|---|---|
| CAGR (2023 to 2033) | 8.0% |
The oral route of administration is dominating the market and is expected to grow at a CAGR of 8.0% over the forecast period, with a market share of about 48.7% in the global market in 2031. Oral medications are quite advantageous as compared to parental and topical medications. These advantages include patient preference, the convenience of drug administration, and cost-effectiveness.
| Top Distribution Channel | Hospital pharmacies |
|---|---|
| CAGR (2023 to 2033) | 9.1% |
Hospital pharmacies hold a prominent market share value of 42.9% during the year 2022 with a CAGR of 9.1%. The increasing number of hospital pharmacies is a factor contributing to the prominent share of hospital pharmacies in the distribution channel category.
The market is a highly fragmented market with numerous key players. To meet consumer demands and strengthen their presence worldwide, these companies are executing a new range of products and regulatory approvals. Few of the key developmental strategies of market players are given below:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, France, Italy, UK, Spain, Russia BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Market Segments Covered | Product, Type, Dosage Forms, Route of Administration, Indication, Distribution Channel and Region |
| Key Companies Profiled | GlaxoSmithKline PLC.; Sanofi Consumer Healthcare; Himalaya Wellness Company; Sun Pharmaceutical Industries, Inc.; Bayer AG; Novartis AG; Cadila Pharmaceuticals; Bausch Health Companies Inc.; Alcon Vision LLC.; Merck & Co.; Dr. Reddy’s Laboratories, Ltd.; Viatris Inc.; Somerset Pharma, LLC; F. Hoffmann- La Roche Ltd.; Akorn Operating Company LLC; Teva Pharmaceutical Industries Ltd.; Speer laboratories; Glenmark Pharmaceuticals Limited; TerSera Therapeutics LLC; Pfizer Inc.; Morepen Laboratories Limited; Johnson & Johnson Services Inc.; Pharmaceutical Specialties Inc.; Proctor & Gamble |
| Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 02: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 03: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 04: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 05: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 06: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 07: Global Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Region
Table 08: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 09: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 10: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 11: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 12: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 13: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 14: North America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 15: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 16: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 17: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 18: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 19: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 20: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 21: Latin America Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 22: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 23: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 24: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 25: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 26: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 27: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 28: Europe Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 29: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 30: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 31: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 32: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 33: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 34: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 35: South Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 36: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 37: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 38: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 39: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 40: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 41: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 42: East Asia Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 43: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 44: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 45: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 46: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 47: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 48: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 49: Oceania Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Table 50: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Country
Table 51: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Product
Table 52: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Type
Table 53: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Dosage Forms
Table 54: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Route of Administration
Table 55: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Indication
Table 56: MEA Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2022 to 2031, by Distribution Channel
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 02: Global Market Value (US$ Million) Forecast, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity, 2023 to 2033
Figure 04: Global Market Share Analysis (%), by Product, 2022 & 2033
Figure 05: Global Market Y-o-Y Analysis (%), by Product, 2023 to 2033
Figure 06: Global Market Attractiveness Analysis by Product, 2023 to 2033
Figure 07: Global Market Share Analysis (%), by Type, 2022 & 2033
Figure 08: Global Market Y-o-Y Analysis (%), by Type, 2023 to 2033
Figure 09: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 10: Global Market Share Analysis (%), by Dosage Forms, 2023 & 2033
Figure 11: Global Market Y-o-Y Analysis (%), by Dosage Forms, 2023 to 2033
Figure 12: Global Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 13: Global Market Share Analysis (%), by Route of Administration, 2023 & 2033
Figure 14: Global Market Y-o-Y Analysis (%), by Route of Administration, 2023 to 2033
Figure 15: Global Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 16: Global Market Share Analysis (%), by Indication, 2023 & 2033
Figure 17: Global Market Y-o-Y Analysis (%), by Indication, 2023 to 2033
Figure 18: Global Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 19: Global Market Share Analysis (%), by Distribution Channel, 2023 & 2033
Figure 20: Global Market Y-o-Y Analysis (%), by Distribution Channel, 2023 to 2033
Figure 21: Global Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 22: Global Market Share Analysis (%), by Region, 2023 & 2033
Figure 23: Global Market Y-o-Y Analysis (%), by Region, 2023 to 2033
Figure 24: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 25: North America Market Split by Country, 2023 (E)
Figure 26: North America Market Split by Product, 2023 (E)
Figure 27: North America Market Split by Type, 2023 (E)
Figure 28: North America Market Split by Dosage Forms, 2023 (E)
Figure 29: North America Market Split by Route of Administration, 2023 (E)
Figure 30: North America Market Split by Indication, 2023 (E)
Figure 31: North America Market Split by Distribution Channel, 2023 (E)
Figure 32: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 33: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 35: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 36: North America Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 37: North America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 38: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 39: North America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 40: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 41: USA Market Split by Product, 2023 (E)
Figure 42: USA Market Split by Type, 2023 (E)
Figure 43: USA Market Split by Dosage Forms, 2023 (E)
Figure 44: USA Market Split by Route of Administration, 2023 (E)
Figure 45: USA Market Split by Indication, 2023 (E)
Figure 46: USA Market Split by Distribution Channel, 2023 (E)
Figure 47: USA Market Value (US$ Million) Analysis, 2017 to 2022
Figure 48: USA Market Value (US$ Million) Forecast, 2023 to 2033
Figure 49: USA Market Attractiveness Analysis by Product, 2023 to 2033
Figure 50: USA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 51: USA Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 52: USA Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 53: USA Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 54: USA Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 55: Canada Market Value Proportion Analysis, 2022
Figure 56: Canada Market, Global Vs. Canada Growth Y-o-Y (%) Comparison, 2022–2033
Figure 57: Canada Market Share Analysis (%) by Product, 2022 & 2033
Figure 58: Canada Market Share Analysis (%) by Type, 2022 & 2033
Figure 59: Canada Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 60: Canada Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 61: Canada Market Share Analysis (%) by Indication, 2022 & 2033
Figure 62: Canada Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 63: Latin America Market Split by Country, 2023 (E)
Figure 64: Latin America Market Split by Product, 2023 (E)
Figure 65: Latin America Market Split by Type, 2023 (E)
Figure 66: Latin America Market Split by Dosage Forms, 2023 (E)
Figure 67: Latin America Market Split by Route of Administration, 2023 (E)
Figure 68: Latin America Market Split by Indication, 2023 (E)
Figure 69: Latin America Market Split by Distribution Channel, 2023 (E)
Figure 70: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 71: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 72: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 73: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 74: Latin America Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 75: Latin America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 76: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 77: Latin America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 78: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 79: Brazil Market Value Proportion Analysis, 2022
Figure 80: Brazil Market, Global Vs. Brazil Growth Y-o-Y (%) Comparison, 2022–2033
Figure 81: Brazil Market Share Analysis (%) by Product, 2022 & 2033
Figure 82: Brazil Market Share Analysis (%) by Type, 2022 & 2033
Figure 83: Brazil Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 84: Brazil Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 85: Brazil Market Share Analysis (%) by Indication, 2022 & 2033
Figure 86: Brazil Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 87: Mexico Market Value Proportion Analysis, 2022
Figure 88: Mexico Market, Global Vs. Mexico Growth Y-o-Y (%) Comparison, 2022–2033
Figure 89: Mexico Market Share Analysis (%) by Product, 2022 & 2033
Figure 90: Mexico Market Share Analysis (%) by Type, 2022 & 2033
Figure 91: Mexico Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 92: Mexico Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 93: Mexico Market Share Analysis (%) by Indication, 2022 & 2033
Figure 94: Mexico Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 95: Argentina Market Value Proportion Analysis, 2022
Figure 96: Argentina Market, Global Vs. Argentina Growth Y-o-Y (%) Comparison, 2022–2033
Figure 97: Argentina Market Share Analysis (%) by Product, 2022 & 2033
Figure 98: Argentina Market Share Analysis (%) by Type, 2022 & 2033
Figure 99: Argentina Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 100: Argentina Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 101: Argentina Market Share Analysis (%) by Indication, 2022 & 2033
Figure 102: Argentina Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 103: Europe Market Split by Country, 2023 (E)
Figure 104: Europe Market Split by Product, 2023 (E)
Figure 105: Europe Market Split by Type, 2023 (E)
Figure 106: Europe Market Split by Dosage Forms, 2023 (E)
Figure 107: Europe Market Split by Route of Administration, 2023 (E)
Figure 108: Europe Market Split by Indication, 2023 (E)
Figure 109: Europe Market Split by Distribution Channel, 2023 (E)
Figure 110: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 111: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 112: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 113: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 114: Europe Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 115: Europe Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 116: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 117: Europe Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 118: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 119: UK Market Value Proportion Analysis, 2022
Figure 120: UK Market, Global Vs. UK Growth Y-o-Y (%) Comparison, 2022–2033
Figure 121: UK Market Share Analysis (%) by Product, 2022 & 2033
Figure 122: UK Market Share Analysis (%) by Type, 2022 & 2033
Figure 123: UK Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 124: UK Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 125: UK Market Share Analysis (%) by Indication, 2022 & 2033
Figure 126: UK Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 127: Germany Market Value Proportion Analysis, 2022
Figure 128: Germany Market, Global Vs. Germany Growth Y-o-Y (%) Comparison, 2022–2033
Figure 129: Germany Market Share Analysis (%) by Product, 2022 & 2033
Figure 130: Germany Market Share Analysis (%) by Type, 2022 & 2033
Figure 131: Germany Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 132: Germany Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 133: Germany Market Share Analysis (%) by Indication, 2022 & 2033
Figure 134: Germany Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 135: France Market Value Proportion Analysis, 2022
Figure 136: France Market, Global Vs. France Growth Y-o-Y (%) Comparison, 2022–2033
Figure 137: France Market Share Analysis (%) by Product, 2022 & 2033
Figure 138: France Market Share Analysis (%) by Type, 2022 & 2033
Figure 139: France Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 140: France Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 141: France Market Share Analysis (%) by Indication, 2022 & 2033
Figure 142: France Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 143: Italy Market Value Proportion Analysis, 2022
Figure 144: Italy Market, Global Vs. Italy Growth Y-o-Y (%) Comparison, 2022–2033
Figure 145: Italy Market Share Analysis (%) by Product, 2022 & 2033
Figure 146: Italy Market Share Analysis (%) by Type, 2022 & 2033
Figure 147: Italy Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 148: Italy Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 149: Italy Market Share Analysis (%) by Indication, 2022 & 2033
Figure 150: Italy Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 151: Spain Market Value Proportion Analysis, 2022
Figure 152: Spain Market, Global Vs. Spain Growth Y-o-Y (%) Comparison, 2022–2033
Figure 153: Spain Market Share Analysis (%) by Product, 2022 & 2033
Figure 154: Spain Market Share Analysis (%) by Type, 2022 & 2033
Figure 155: Spain Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 156: Spain Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 157: Spain Market Share Analysis (%) by Indication, 2022 & 2033
Figure 158: Spain Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 159: Russia Market Value Proportion Analysis, 2022
Figure 160: Russia Market, Global Vs. Russia Growth Y-o-Y (%) Comparison, 2022–2033
Figure 161: Russia Market Share Analysis (%) by Product, 2022 & 2033
Figure 162: Russia Market Share Analysis (%) by Type, 2022 & 2033
Figure 163: Russia Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 164: Russia Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 165: Russia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 166: Russia Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 167: BENELUX Market Value Proportion Analysis, 2022
Figure 168: BENELUX Market, Global Vs. BENELUX Growth Y-o-Y (%) Comparison, 2022–2033
Figure 169: BENELUX Market Share Analysis (%) by Product, 2022 & 2033
Figure 170: BENELUX Market Share Analysis (%) by Type, 2022 & 2033
Figure 171: BENELUX Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 172: BENELUX Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 173: BENELUX Market Share Analysis (%) by Indication, 2022 & 2033
Figure 174: BENELUX Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 175: Nordic Countries Market Value Proportion Analysis, 2022
Figure 176: Nordic Countries Market, Global Vs. Nordic Countries Growth Y-o-Y (%) Comparison, 2022–2033
Figure 177: Nordic Countries Market Share Analysis (%) by Product, 2022 & 2033
Figure 178: Nordic Countries Market Share Analysis (%) by Type, 2022 & 2033
Figure 179: Nordic Countries Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 180: Nordic Countries Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 181: Nordic Countries Market Share Analysis (%) by Indication, 2022 & 2033
Figure 182: Nordic Countries Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 183: South Asia Market Split by Country, 2023 (E)
Figure 184: South Asia Market Split by Product, 2023 (E)
Figure 285: South Asia Market Split by Type, 2023 (E)
Figure 186: South Asia Market Split by Dosage Forms, 2023 (E)
Figure 187: South Asia Market Split by Route of Administration, 2023 (E)
Figure 188: South Asia Market Split by Indication, 2023 (E)
Figure 189: South Asia Market Split by Distribution Channel, 2023 (E)
Figure 190: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 191: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 192: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 193: South Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 194: South Asia Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 195: South Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 196: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 197: South Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 198: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 199: India Market Value Proportion Analysis, 2022
Figure 200: India Market, Global Vs. India Growth Y-o-Y (%) Comparison, 2022–2033
Figure 201: India Market Share Analysis (%) by Product, 2022 & 2033
Figure 202: India Market Share Analysis (%) by Type, 2022 & 2033
Figure 203: India Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 204: India Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 205: India Market Share Analysis (%) by Indication, 2022 & 2033
Figure 206: India Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 207: Thailand Market Value Proportion Analysis, 2022
Figure 208: Thailand Market, Global Vs. Thailand Growth Y-o-Y (%) Comparison, 2022–2033
Figure 209: Thailand Market Share Analysis (%) by Product, 2022 & 2033
Figure 210: Thailand Market Share Analysis (%) by Type, 2022 & 2033
Figure 211: Thailand Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 212: Thailand Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 213: Thailand Market Share Analysis (%) by Indication, 2022 & 2033
Figure 214: Thailand Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 215: Indonesia Market Value Proportion Analysis, 2022
Figure 216: Indonesia Market, Global Vs. Indonesia Growth Y-o-Y (%) Comparison, 2022–2033
Figure 217: Indonesia Market Share Analysis (%) by Product, 2022 & 2033
Figure 218: Indonesia Market Share Analysis (%) by Type, 2022 & 2033
Figure 219: Indonesia Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 220: Indonesia Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 221: Indonesia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 222: Indonesia Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 223: Malaysia Market Value Proportion Analysis, 2022
Figure 224: Malaysia Market, Global Vs. Malaysia Growth Y-o-Y (%) Comparison, 2022–2033
Figure 225: Malaysia Market Share Analysis (%) by Product, 2022 & 2033
Figure 226: Malaysia Market Share Analysis (%) by Type, 2022 & 2033
Figure 227: Malaysia Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 228: Malaysia Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 229: Malaysia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 230: Malaysia Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 231: East Asia Market Split by Country, 2023 (E)
Figure 232: East Asia Market Split by Product, 2023 (E)
Figure 233: East Asia Market Split by Type, 2023 (E)
Figure 234: East Asia Market Split by Dosage Forms, 2023 (E)
Figure 235: East Asia Market Split by Route of Administration, 2023 (E)
Figure 236: East Asia Market Split by Indication, 2023 (E)
Figure 237: East Asia Market Split by Distribution Channel, 2023 (E)
Figure 238: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 239: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 240: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 241: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 242: East Asia Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 243: East Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 244: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 245: East Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 246: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 247: China Market Value Proportion Analysis, 2022
Figure 248: China Market, Global Vs. China Growth Y-o-Y (%) Comparison, 2022–2033
Figure 249: China Market Share Analysis (%) by Product, 2022 & 2033
Figure 250: China Market Share Analysis (%) by Type, 2022 & 2033
Figure 251: China Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 252: China Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 253: China Market Share Analysis (%) by Indication, 2022 & 2033
Figure 254: China Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 255: Japan Market Value Proportion Analysis, 2022
Figure 256: Japan Market, Global Vs. Japan Growth Y-o-Y (%) Comparison, 2022–2033
Figure 257: Japan Market Share Analysis (%) by Product, 2022 & 2033
Figure 258: Japan Market Share Analysis (%) by Type, 2022 & 2033
Figure 259: Japan Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 260: Japan Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 261: Japan Market Share Analysis (%) by Indication, 2022 & 2033
Figure 262: Japan Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 263: South Korea Market Value Proportion Analysis, 2022
Figure 264: South Korea Market, Global Vs. South Korea Growth Y-o-Y (%) Comparison, 2022–2033
Figure 265: South Korea Market Share Analysis (%) by Product, 2022 & 2033
Figure 266: South Korea Market Share Analysis (%) by Type, 2022 & 2033
Figure 267: South Korea Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 268: South Korea Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 269: South Korea Market Share Analysis (%) by Indication, 2022 & 2033
Figure 270: South Korea Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 271: Oceania Market Split by Country, 2023 (E)
Figure 272: Oceania Market Split by Product, 2023 (E)
Figure 273: Oceania Market Split by Type, 2023 (E)
Figure 274: Oceania Market Split by Dosage Forms, 2023 (E)
Figure 275: Oceania Market Split by Route of Administration, 2023 (E)
Figure 276: Oceania Market Split by Indication, 2023 (E)
Figure 277: Oceania Market Split by Distribution Channel, 2023 (E)
Figure 278: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 279: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 280: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 281: Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 282: Oceania Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 283: Oceania Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 284: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 285: Oceania Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 286: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 287: Australia Market Value Proportion Analysis, 2022
Figure 288: Australia Market, Global Vs. Australia Growth Y-o-Y (%) Comparison, 2022–2033
Figure 289: Australia Market Share Analysis (%) by Product, 2022 & 2033
Figure 290: Australia Market Share Analysis (%) by Type, 2022 & 2033
Figure 291: Australia Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 292: Australia Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 293: Australia Market Share Analysis (%) by Indication, 2022 & 2033
Figure 294: Australia Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 295: New Zealand Market Value Proportion Analysis, 2022
Figure 296: New Zealand Market, Global Vs. New Zealand Growth Y-o-Y (%) Comparison, 2022–2033
Figure 297: New Zealand Market Share Analysis (%) by Product, 2022 & 2033
Figure 298: New Zealand Market Share Analysis (%) by Type, 2022 & 2033
Figure 299: New Zealand Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 300: New Zealand Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 301: New Zealand Market Share Analysis (%) by Indication, 2022 & 2033
Figure 302: New Zealand Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 303: Middle East and Africa Market Split by Country, 2023 (E)
Figure 304: Middle East and Africa Market Split by Product, 2023 (E)
Figure 305: Middle East and Africa Market Split by Type, 2023 (E)
Figure 306: Middle East and Africa Market Split by Dosage Forms, 2023 (E)
Figure 307: Middle East and Africa Market Split by Route of Administration, 2023 (E)
Figure 308: Middle East and Africa Market Split by Indication, 2023 (E)
Figure 309: Middle East and Africa Market Split by Distribution Channel, 2023 (E)
Figure 310: Middle East and Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 311: Middle East and Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 312: Middle East and Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 313: Middle East and Africa Market Attractiveness Analysis by Type, 2023 to 2033
Figure 314: Middle East and Africa Market Attractiveness Analysis by Dosage Forms, 2023 to 2033
Figure 315: Middle East and Africa Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 316: Middle East and Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 317: Middle East and Africa Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 318: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 319: Türkiye Market Value Proportion Analysis, 2022
Figure 320: Türkiye Market, Global Vs. Türkiye Growth Y-o-Y (%) Comparison, 2022–2033
Figure 321: Türkiye Market Share Analysis (%) by Product, 2022 & 2033
Figure 322: Türkiye Market Share Analysis (%) by Type, 2022 & 2033
Figure 323: Türkiye Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 324: Türkiye Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 325: Türkiye Market Share Analysis (%) by Indication, 2022 & 2033
Figure 326: Türkiye Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 327: GCC Countries Market Value Proportion Analysis, 2022
Figure 328: GCC Countries Market, Global Vs. GCC Countries Growth Y-o-Y (%) Comparison, 2022–2033
Figure 329: GCC Countries Market Share Analysis (%) by Product, 2022 & 2033
Figure 330: GCC Countries Market Share Analysis (%) by Type, 2022 & 2033
Figure 331: GCC Countries Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 332: GCC Countries Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 333: GCC Countries Market Share Analysis (%) by Indication, 2022 & 2033
Figure 334: GCC Countries Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 335: Northern Africa Market Value Proportion Analysis, 2022
Figure 336: Northern Africa Market, Global Vs. North Africa Growth Y-o-Y (%) Comparison, 2022–2033
Figure 337: Northern Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 338: Northern Africa Market Share Analysis (%) by Type, 2022 & 2033
Figure 339: Northern Africa Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 340: Northern Africa Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 341: Northern Africa Market Share Analysis (%) by Indication, 2022 & 2033
Figure 342: Northern Africa Market Share Analysis (%) by Distribution Channel, 2022 & 2033
Figure 343: South Africa Market Value Proportion Analysis, 2022
Figure 344: South Africa Market, Global Vs. South Africa Growth Y-o-Y (%) Comparison, 2022–2033
Figure 345: South Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 346: South Africa Market Share Analysis (%) by Type, 2022 & 2033
Figure 347: South Africa Market Share Analysis (%) by Dosage Forms, 2022 & 2033
Figure 348: South Africa Market Share Analysis (%) by Route of Administration, 2022 & 2033
Figure 349: South Africa Market Share Analysis (%) by Indication, 2022 & 2033
Figure 350: South Africa Market Share Analysis (%) by Distribution Channel, 2022 & 2033
The global antihistamine market is worth USD 263.9 billion in 2022.
The antihistamine market is expected to reach USD 647.7 billion by 2033, growing at a CAGR of 8.6% over the forecast period.
Increased efficacy of antihistamines with respect to relieving symptoms and allergic reactions across the globe.
North America dominated the global antihistamine market accounting for a prominent market share of 34.6%.
The market in India is likely to grow with a CAGR of 7.8% over the forecast period.
The United States, China, the United Kingdom, Germany, and India are the top five countries, which are expected to drive demand for antihistamines.
Explore Similar Insights
Antihistamine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
